No abstract available.
Candidiasis*

No abstract available.
Candidiasis*

No abstract available.
Candidiasis, Cutaneous*

No abstract available.
Candidiasis* ; Fluconazole*

No abstract available.
Candidiasis, Oral* ; Fluconazole*

No abstract available.
Candidiasis* ; Fluconazole* ; Humans

The development of traumatology and orthopedic profession based on the advancements of modern equipment of imaging diagnosis. The microsurgery has been applied and gave many good outcomes. The laparoscopic articular surgery can diagnose and reconstruct and regenerate many intraarticular lesions that not require the articular open. The expanded and stretched bone filling and compression can reconstruct the major bone defect without bone transplantation. The close bone filling helped easy and rapid healing and had less risk of infection
Opportunistic Infections ; Candidiasis

No abstract available.
Candidiasis* ; Diabetes Mellitus*

Recurrent vaginal candidiasis is one of the most common reasons for patients visiting their primary care doctors. Majority of the cases are caused by Candida albicans. Controlling of risk factors such as diabetes mellitus, used of broad spectrum antibiotics, contraceptive pills and steroid therapy helps in managing recurrent vaginal candidiasis. Initial 14-day course of oral azoles and followed by 6 months maintenance are effective in treating majority of the cases. Failure to treat recurrent vaginal candidiasis can lead to various bio-psycho-social complications.
*Candidiasis, Vulvovaginal ; Recurrence

BACKGROUND

Candida infections range from oral candidiasis to candida endophthalmitis, peritonitis and candidemia. Invasive fungal disease or disseminated candidiasis is highly fatal among children. There are no studies done in the pediatric population to detect early candida infection to help identify those who will benefit from early and prompt medical treatment.

This study determined the value of Candida scoring (CS) as a predictive tool for invasive candidiasis among pediatric patients admitted in the intensive care units of a tertiary referral center.

This was a retrospective cross sectional study where 4184 charts of pediatric patients and admitted in the ICU between January 2018 to December 2020 were reviewed. Patients were scored upon admission, after 3 days, after 1 week and weekly thereafter until discharge or demise. The scoring tool used was developed by Leon et al., and uses four variables: presence of sepsis, use of total parenteral nutrition (TPN), presence of multifocal colonization and presence of surgery. Data collected for Candida scores were presented as frequencies and percentages.

There were 396 patients enrolled in this study and 25.7% were treated for candida infection. Majority were newborns where 78.7% had a CS >3, which is statistically significant, p =3 which is statistically significant. Among intubated patients, 84% had a CS of >3 and all patients on TPN had a CS of >3, both of which are significant. CS could correctly predict 64.6% of patients who will likely have candida infection.

Candida scoring is a tool that can be used in patients at high risk of developing Candida infection. In this study, a CS of >3 can be used to predict Candida infection in the ICU.